SCHEMBL17996239

SCHEMBL17996239

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5cccc6c(-c7ccc(-c8cc(-c9ccc(-c%10ccccc%10)cc9)nc(-c9ccccc9)n8)cc7)cccc56)cc4)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.59
▸ KMT2A Q03164 9/20 0.59
▸ ALDH1A1 P00352 7/20 0.59
▸ HPGD P15428 7/20 0.59
▸ MAPT P10636 6/20 0.59
▸ NTSR1 P30989 1/20 0.59
▸ KDM4E B2RXH2 4/20 0.56
▸ LMNA P02545 2/20 0.56
▸ GLA P06280 1/20 0.56
▸ ADORA2A P29274 2/20 0.52
▸ ADORA1 P30542 2/20 0.52
▸ ACACA Q13085 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ MAOA P21397 3/20 0.46
▸ MAOB P27338 3/20 0.46
▸ DHODH Q02127 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17969991 1.00 MEN1 (0.59) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17969940 1.00 MEN1 (0.59) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17969969 1.00 MEN1 (0.59) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17969934 1.00 MEN1 (0.59) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17996238 1.00 MEN1 (0.59) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17996240 1.00 MEN1 (0.59) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17969992 1.00 MEN1 (0.59) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17970020 0.98 MEN1 (0.61) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17970014 0.98 MEN1 (0.61) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL21131717 0.96 MEN1 (0.65) MEN1KMT2AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9954181-B2 Hetero-cyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2018-04-24 — — US disclosed
US-9954181-B2 Hetero-cyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2018-04-24 — — US disclosed
US-20160233430-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME (As Amended) LG CHEM, LTD. (KR) 2016-08-11 — — US disclosed
US-20160233430-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME (As Amended) LG CHEM, LTD. (KR) 2016-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160233430-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME (As Amended) CRY1, CRY2, PER2 MEN1 1048/4885KMT2A 986/4885ALDH1A1 1790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback